PFIZER INC (PFE)

↓ Download CSV

CIK 0000078003 · NYSE · Pharmaceutical Preparations

  • Sector Manufacturing
  • Incorporated DE
  • Fiscal year ends Dec 31

In fiscal 2025, PFIZER INC reported revenue of $62.58B, down 1.6% from the prior year. The company was profitable, with a net margin of 12.4%. It held $208.16B in total assets against $121.39B in total liabilities.

Key ratios (FY2025)

12.4%
Net margin
9.0%
Return on equity
-1.6%
Revenue growth (YoY)
Metric (FY)2025202420232022202120202019201820172016
Revenue$62.58B$63.63B$59.55B$101.17B$81.29B$41.65B
Cost of Revenue$16.07B$17.85B$24.95B$34.34B$30.82B$8.48B$8.05B$8.99B$11.23B$12.32B
Net Income$7.77B$8.03B$2.12B$31.37B$21.98B$9.16B$16.03B$11.15B$21.31B$7.21B
EPS (Diluted)$1.36$1.41$0.37$5.47$3.85$1.63$2.82$1.87$3.52$1.17
Total Assets$208.16B$213.40B$226.50B$197.21B$181.48B$154.23B$167.59B$159.42B$171.80B$171.62B
Total Liabilities$121.39B$124.90B$137.21B$101.29B$104.01B$90.76B$104.15B$95.66B$100.14B$111.78B
Shareholders' Equity$86.78B$88.50B$89.29B$95.92B$77.46B$63.47B$63.45B$63.76B$71.66B$59.84B
Cash & Equivalents$1.14B$1.04B$2.85B$416.00M$1.94B$1.79B$1.12B$1.14B$1.34B$2.60B
Operating Cash Flow$11.70B$12.74B$8.70B$29.27B$32.58B$14.40B$12.59B$15.83B$16.80B$16.19B
Capital Expenditures$2.63B$2.91B$3.91B$3.24B$2.71B$2.23B$2.05B$1.98B$1.96B$1.82B
Shares Outstanding5.71B5.70B5.71B5.73B5.71B5.63B5.67B5.98B6.06B6.16B
Dividends Per Share$1.72$1.69$1.65$1.61$1.57$1.53$1.46$1.38$1.30$1.22